Mavyret Approved for Hepatitis C

FRIDAY, Aug. 4, 2017 –Mavyret (glecaprevir and pibrentasvir) has been approved by the U.S. Food and Drug Administration to treat adults with certain types of chronic hepatitis C virus (HCV).
The combination drug is the first approved therapy for…
Source: Topamax